Updated: May 2026
If one area of medical AI has moved beyond vague promise, it is imaging. Radiology has digital data, measurable endpoints, and many regulated tools. But even here, the best evidence supports AI as assistance, not replacement.
Short answer: AI in radiology is useful for triage, detection support, workload reduction, and second-reader workflows. The strongest evidence is in narrow imaging tasks, especially mammography screening. The safest model is AI plus radiologist, not AI alone.
Why radiology became the first big medical AI field
Radiology is attractive for AI because the input is already digital. X-rays, CT scans, MRIs, mammograms, and ultrasound images can be stored, labelled, compared, and audited. A model can be trained to detect a specific finding: intracranial hemorrhage, pulmonary embolism, lung nodule, fracture, pneumothorax, tuberculosis-like opacity, or breast cancer.
This is very different from asking AI to “manage a child with fever.” Imaging tasks are narrower. That makes evidence easier to generate.
The MASAI trial: what good AI evidence looks like
The Mammography Screening with Artificial Intelligence trial, or MASAI, is one of the most useful studies because it was randomized, large, and tested in a real screening workflow.
| Data point | MASAI result |
|---|---|
| Study design | Randomized, controlled, non-inferiority screening accuracy study |
| Participants randomized | 80,033 women |
| AI-supported arm | 40,003 assigned |
| Control arm | 40,030 assigned to standard double reading |
| Cancer detection | 6.1 per 1000 with AI vs 5.1 per 1000 control |
| False positive rate | 1.5% in both groups |
| Screen-reading workload | Reduced by 44.3% |
This is a much stronger claim than saying “AI is accurate.” It tells us what happened when AI was inserted into a real radiology workflow.
What AI can do well in radiology
- Triage urgent scans: move suspected intracranial bleed, pneumothorax, or pulmonary embolism higher in the queue.
- Act as a second reader: highlight suspicious areas for radiologists.
- Reduce repetitive workload: help sort low-risk screening images.
- Improve consistency: support measurements such as nodule size or cardiac indices.
- Support peripheral hospitals: help non-specialist teams decide which images need urgent referral.
What radiology AI cannot solve
AI does not know the whole patient unless the system is designed to include clinical context. A chest X-ray model may flag opacity, but it does not know whether the child has tuberculosis exposure, congenital heart disease, severe anemia, aspiration risk, or previous pneumonia unless those data are available.
AI can also fail silently. A false negative in triage may delay reporting. A false positive may overload radiologists and increase unnecessary tests. Both matter.
Why local validation matters in Nepal
Nepal’s imaging reality is not uniform. A CT from a tertiary hospital in Kathmandu, a chest X-ray from a district hospital, and a mobile screening image from a camp may differ in quality. Protocols differ. Machines differ. Patient populations differ.
If a radiology AI tool was trained mostly on high-income-country images, we should ask whether it performs well on Nepali patients, Nepali disease patterns, and Nepali image quality.
Potential uses in Nepal
- Chest X-ray triage for tuberculosis screening support.
- Emergency CT head triage for suspected hemorrhage.
- Fracture detection in high-volume emergency settings.
- Neonatal chest X-ray quality and line/tube position support.
- Mammography workflow support where radiologist workload is high.
Procurement checklist for hospitals
- Ask for external validation data, not only vendor slides.
- Ask whether the tool was tested in South Asian populations.
- Ask for false negative examples.
- Ask how model updates are handled.
- Run a silent local pilot before relying on it clinically.
- Keep the radiologist responsible for the final report.
- Audit missed cases and overcalls after deployment.
My take
Radiology AI is probably the most mature part of medical AI today. It can reduce workload and improve detection in the right workflow. But the safest use is still radiologist-led.
For Nepal, the opportunity is real. The mistake would be buying AI like a shortcut instead of implementing it like a clinical service that needs validation, audit, training, and accountability.
Sources checked
- The Lancet Oncology: MASAI trial clinical safety analysis
- Nature Medicine: Nationwide real-world implementation of AI in mammography screening
- Stanford HAI: 2026 AI Index, Medicine chapter
- FDA: AI/ML-enabled medical devices
No spam. Just a short email when I publish something new.